Skip Ribbon Commands
Skip to main content
Skip to main navigation Skip to main content
Sign In
Restrict your results by using the refiners below:
Search

​​​​​​​​​​​​​​​​​​​​​Narrow Your Results:​

 

 

AUTH/2868/8/16 - Janssen v Sanofi Genzyme 352310/03/2017 15:00:32Janssen noted that in January 2016 Sanofi Genzyme announced that the US Food and Drug be viewed in the context of Sanofi Genzyme’s other activities about IL-6 at the conference STS_ListItem_PublishingPageshttp://www.pmcpa.org.uk/cases/Pages/Forms/AllItems.aspx0http://www.pmcpa.org.uk10/03/2017 15:00:32htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2821/2/16 - Voluntary admission by Sanofi Genzyme 348130/06/2016 13:27:52Status:The respondent can appeal Review:Published in the May The Panel noted that in 2015 Sanofi Genzyme had taken a table of ten. It appeared that it STS_ListItem_PublishingPageshttp://www.pmcpa.org.uk/cases/Pages/Forms/AllItems.aspx0http://www.pmcpa.org.uk30/06/2016 13:27:52htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2809/12/15 - Genzyme v Amicus Therapeutics346930/06/2016 11:13:55Appeal:Appeal by the respondent Review:Published in the May Genzyme (now Sanofi Genzyme) complained about a 30 minute presentation given by Amicus STS_ListItem_PublishingPageshttp://www.pmcpa.org.uk/cases/Pages/Forms/AllItems.aspx0http://www.pmcpa.org.uk30/06/2016 11:13:55htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2721/7/14 - Shire v Genzyme 339330/06/2016 09:46:52Before the meeting, Genzyme circulated a written narrative, ‘Genzyme proposal to NHS England for major cost As a result of these rumours Genzyme sought to clarify the situation STS_ListItem_PublishingPageshttp://www.pmcpa.org.uk/cases/Pages/Forms/AllItems.aspx0http://www.pmcpa.org.uk30/06/2016 09:46:52htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AstraZeneca and Genzyme named in advertisements following breaches of the ABPI Code108501/07/2016 10:36:16patient safety, that it decided to require Genzyme to issue a corrective statement to all Both the complainant and the respondent company may appeal to the Code of Practice Appeal STS_ListItem_PublishingPageshttp://www.pmcpa.org.uk/media/Pages/Forms/AllItems.aspx0http://www.pmcpa.org.uk01/07/2016 10:36:16htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2528/8/12 - Genzyme v Shire 323406/06/2014 14:17:27Appeal:Appeal by respondent and complainant Status:Breach Genzyme noted that Shire had placed the press release on its global website and had also STS_ListItem_PublishingPageshttp://www.pmcpa.org.uk/cases/Pages/Forms/AllItems.aspx0http://www.pmcpa.org.uk06/06/2014 14:17:27htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
2721 May 2016180421/06/2016 14:32:39Before the meeting, Genzyme circulated a written narrative, ‘Genzyme proposal to NHS England for major cost As a result of these rumours Genzyme sought to clarify the situation STS_ListItem_DocumentLibraryhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FDocuments%2F2014%2F2721%20May%202016%2Epdf&action=interactivepreviewhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FDocuments%2F2014%2F2721%20May%202016%2Epdf&action=imagepreviewhttp://www.pmcpa.org.uk/cases/Documents/20140http://www.pmcpa.org.uk21/06/2016 14:32:39pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
2016 May Review80421/06/2016 14:30:43NUMBER 92 May 2016 CODE OF PRACTICE REVIEW The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry STS_ListItem_DocumentLibraryhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FCode%20of%20Practice%20Reviews%2F2016%20May%20Review%2Epdf&action=interactivepreviewhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FCode%20of%20Practice%20Reviews%2F2016%20May%20Review%2Epdf&action=imagepreviewhttp://www.pmcpa.org.uk/cases/Code of Practice Reviews/Forms/AllItems.aspx0http://www.pmcpa.org.uk21/06/2016 14:30:43pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
2013 May Review79220/05/2013 14:44:40NUMBER 80 May 2013 CODE OF PRACTICE REVIEW The Prescription Medicines Code of Practice Authority was established by The Association of the British Pharmaceutical Industry (ABPI STS_ListItem_DocumentLibraryhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FCode%20of%20Practice%20Reviews%2F2013%20May%20Review%2Epdf&action=interactivepreviewhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FCode%20of%20Practice%20Reviews%2F2013%20May%20Review%2Epdf&action=imagepreviewhttp://www.pmcpa.org.uk/cases/Code of Practice Reviews/Forms/AllItems.aspx0http://www.pmcpa.org.uk20/05/2013 14:44:40pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
February 2017 Review5104613/03/2017 15:24:37NUMBER 95 February 2017 CODE OF PRACTICE REVIEW The Prescription Medicines Code of Practice When she started at the PMCPA respondent companies were notified of a complaint by STS_ListItem_DocumentLibraryhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FCode%20of%20Practice%20Reviews%2F2017%20February%20Review%20%2D%2Epdf&action=interactivepreviewhttp://www.pmcpa.org.uk/cases/_layouts/15/WopiFrame.aspx?sourcedoc=%2Fcases%2FCode%20of%20Practice%20Reviews%2F2017%20February%20Review%20%2D%2Epdf&action=imagepreviewhttp://www.pmcpa.org.uk/cases/Code of Practice Reviews/Forms/AllItems.aspx0http://www.pmcpa.org.uk13/03/2017 15:24:37pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js

Restrict your results by using the refiners below:
Related links